Monoclonal antibody and preparation method thereof

A monoclonal antibody, nucleotide sequence technology, applied in the field of medicine, can solve the problems of large toxic and side effects, the antibody does not have high affinity, and does not have high specificity

Inactive Publication Date: 2017-02-15
BINZHOU MEDICAL COLLEGE
View PDF1 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] The purpose of the present invention is to provide a monoclonal antibody and its preparation method, aiming to solve the problem that the prior art antibody does not have high affinity, no high specificity,

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Monoclonal antibody and preparation method thereof
  • Monoclonal antibody and preparation method thereof
  • Monoclonal antibody and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0113] Such as figure 1 Shown: the preparation method of the monoclonal antibody provided by the embodiment of the present invention comprises the following steps:

[0114] S101: immunize mice with PGAM, CoIα, Trx, PGAM13, CoIα12, Trx11 by intrasplenic embedding;

[0115] S102: Fusion of splenocytes from immunized mice with mouse myeloma cells SP2 / 0;

[0116] S103: Detect the cell culture supernatant by indirect ELISA.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a monoclonal antibody and a preparation method thereof. The monoclonal antibody comprises anti-PGAM, CoI alpha, Trx, PGAM 13, CoI alpha 12 and Trx 11. The preparation method comprises the following steps: immunizing mice by embedding PGAM, CoI alpha, Trx, PGAM 13, CoI alpha 2 and Trx 11 in spleens; fusing spleen cells of the mice with myeloma cells SP2/0 of the mice; and detecting the cells by indirect ELISA and culturing supernatant. 3, 2, 5, 3, 4 and 3 strains of monoclonal antibodies for resisting PGAM, CoI alpha, Trx, PGAM 13, CoI alpha 12 and Trx 11 are respectively obtained, and homotypes of the antibodies are IgM.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a monoclonal antibody and a preparation method thereof. Background technique [0002] The main function of antibodies is to combine with antigens (including foreign and self), so as to effectively remove foreign substances such as microorganisms and parasites invading the body, especially monoclonal antibodies, because of their high uniformity and specific antigen expression. Therefore, it is widely used in the fields of immunological analysis, radioimmunoimaging and immune-guided therapy. The development of monoclonal antibodies has gone through four stages, namely: murine monoclonal antibodies, chimeric monoclonal antibodies, humanized monoclonal antibodies and fully human monoclonal antibodies. Mouse-derived monoclonal antibody: mouse hybridoma monoclonal antibody mainly fuses B cells from immunized mice with myeloma cells, and then screens out mouse hybrid fusio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07K16/00C12N15/13
CPCC07K16/00
Inventor 吴玉龙程梅刘士霞周秀芝张莹张玉梅耿丽李波清金昌洙
Owner BINZHOU MEDICAL COLLEGE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products